Clinical Trials

Showing 1 - 20 of 494 trials
Title Investigatorsort icon Disease(s)
A Phase Ib Study of Urelumab Given with Rituximab in Patients with Recurrent or Persistent Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia
Relapsed/Refractory
[Protocol 13-252]
Zelenetz, Andrew
  • Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I/II Study of Sequential Chemoradiation Followed by Autologous Stem Cell Transplant in Patients with Untreated Advanced Mantle Cell Lymphoma
Newly Diagnosed
[Protocol 11-095]
Zelenetz, Andrew
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of CAL-101 plus Rituximab in Elderly Patients with Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
[Protocol 10-224]
Zelenetz, Andrew
  • Leukemia
    • Chronic Lymphocytic Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Bendamustine and Rituximab plus GS-1101 (CAL-101) or Placebo for Previously Treated Chronic Lymphocytic Leukemia
[Protocol 12-189]
Zelenetz, Andrew
  • Leukemia
    • Chronic Lymphocytic Leukemia
A Phase II Study Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Low-Risk Prostate Cancer
[Protocol 11-056]
Zelefsky, Michael
  • Prostate Cancer
    • Localized Disease
A Phase I Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer
[Protocol 09-035]
Zelefsky, Michael
  • Prostate Cancer
    • Localized Disease
A Phase III Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy in Patients with Metastatic Cancer
[Protocol 10-154]
Zelefsky, Michael
A Phase II Study of VS-6063 in Patients with Malignant Pleural Mesothelioma
[Protocol 13-185]
Zauderer, Marjorie
  • Mesothelioma
Intimacy-Enhancing Couples' Intervention for Localized Prostate Cancer
[Protocol 11-112]
Zaider, Talia
  • Prostate Cancer
    • Localized Disease
    • Quality of Life
A Phase I Study of Daily Low-Dose Erlotinib and Twice Weekly High-Dose Erlotinib in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
[Protocol 12-278]
Yu, Helena
A Phase I/II Study of Ruxolitinib plus Erlotinib in Patients with Erlotinib-Resistant Lung Adenocarcinoma
[Protocol 14-043]
Yu, Helena
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase II Study of CO-1686 in Patients with Previously Treated Non-Small Cell Lung Cancer Containing an EGFR T790M Mutation
[Protocol 14-084]
Yu, Helena
  • Lung Cancer, Non-Small Cell
A Phase II Study of Intermittent Dacomitinib in Patients with Advanced Non-Small Cell Lung Cancer
[Protocol 13-036]
Yu, Helena
  • Lung Cancer, Non-Small Cell
A Phase II Study to See if Carvedilol Can Help Prevent Heart Function Problems in Women Receiving Anthracyclines or Anti-HER2 Therapies for Breast Cancer
[Protocol 14-099]
Yu, Anthony
  • Breast Cancer
A Pilot Study of Functional Imaging for Cerebellar Mutism Syndrome
Newly Diagnosed & Relapsed/Refractory
[Protocol 12-121]
Young, Robert
  • Pediatric Brain Tumors
A Phase I Study of an mRNA-Modified Dendritic Cell Vaccine in Patients with Melanoma
[Protocol 10-229]
Young, James
  • Melanoma
A Phase I Study of CPI-0610 in Patients with Progressive Lymphoma
Relapsed/Refractory
[Protocol 13-259]
Younes, Anas
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
A Phase I Study of CB-839 in Patients with Advanced or Persistent Hematologic Cancers
[Protocol 14-053]
Younes, Anas
  • Hematology
    • Hematologic Malignancies
    • Multiple Myeloma
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of BKM120 in Patients with Recurrent or Persistent Diffuse Large B-Cell Lymphoma, Mantle Cell Lymphoma, or Follicular Lymphoma
[Protocol 13-072]
Younes, Anas
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of CUDC-907 in Patients with Relapsed or Refractory Lymphoma or Multiple Myeloma
Relapsed/Refractory
[Protocol 13-045]
Younes, Anas
  • Hematology
    • Multiple Myeloma
  • Lymphoma
    • Non-Hodgkin's Lymphoma